Contrastingly, in the fatal dengue virus infection, macrophages treated with HDAC inhibitor VPA decreased the cytokine production in the infected cells, indicating a novel therapeutic aspect of HDAC inhibitor in treating dengue virus infections [140]. Here, HDAC9 is linked to dengue disease.